Critical Care, ISSN 1364-8535, 10/2009, Volume 13, Issue 5, pp. R169 - R169
Introduction While propofol is associated with an infusion syndrome (PRIS) that may cause death, the incidence of PRIS is unknown. Determining the incidence of...
FATAL MYOCARDIAL FAILURE | ANESTHESIA | METABOLIC-ACIDOSIS | INTENSIVE-CARE-UNIT | CARDIAC-SURGERY | LACTIC-ACIDOSIS | PATIENT | DEATH | RHABDOMYOLYSIS | CHILDREN | CRITICAL CARE MEDICINE | Anesthetics, Intravenous - adverse effects | Intensive Care Units | Arrhythmias, Cardiac - chemically induced | Prospective Studies | Humans | Middle Aged | Critical Illness | Male | Academic Medical Centers | Syndrome | Incidence | Anesthetics, Intravenous - administration & dosage | Adult | Female | Aged | Propofol - administration & dosage | Heart Failure - chemically induced | Propofol - adverse effects | Drugs | Prevention | Complications and side effects | Care and treatment | Critically ill | Patient outcomes | Adverse and side effects | Dosage and administration | Propofol | Risk factors | Research
FATAL MYOCARDIAL FAILURE | ANESTHESIA | METABOLIC-ACIDOSIS | INTENSIVE-CARE-UNIT | CARDIAC-SURGERY | LACTIC-ACIDOSIS | PATIENT | DEATH | RHABDOMYOLYSIS | CHILDREN | CRITICAL CARE MEDICINE | Anesthetics, Intravenous - adverse effects | Intensive Care Units | Arrhythmias, Cardiac - chemically induced | Prospective Studies | Humans | Middle Aged | Critical Illness | Male | Academic Medical Centers | Syndrome | Incidence | Anesthetics, Intravenous - administration & dosage | Adult | Female | Aged | Propofol - administration & dosage | Heart Failure - chemically induced | Propofol - adverse effects | Drugs | Prevention | Complications and side effects | Care and treatment | Critically ill | Patient outcomes | Adverse and side effects | Dosage and administration | Propofol | Risk factors | Research
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 01/2008, Volume 28, Issue 1, pp. 102 - 111
Therapeutic hypothermia has emerged as an effective means of improving neurologic outcomes among cardiac arrest survivors. To achieve optimal results,...
pharmacokinetics | physiology | therapeutic hypothermia | cardiac arrest | pharmacology | Therapeutic hypothermia | Pharmacology | Physiology | Pharmacokinetics | Cardiac arrest | VENTRICULAR-FIBRILLATION | MILD HYPOTHERMIA | RENAL-FUNCTION | CARDIOPULMONARY BYPASS | CRITICALLY-ILL | MYOCARDIAL TEMPERATURE | OXYGEN-UPTAKE | BRETYLIUM TOSYLATE | PHARMACOLOGY & PHARMACY | HEMODYNAMIC-RESPONSES | INTENSIVE INSULIN THERAPY | Hypothermia, Induced - adverse effects | Risk Assessment | Drug Therapy - methods | Humans | Hypothermia, Induced - methods | Heart Arrest - physiopathology | Heart Arrest - therapy
pharmacokinetics | physiology | therapeutic hypothermia | cardiac arrest | pharmacology | Therapeutic hypothermia | Pharmacology | Physiology | Pharmacokinetics | Cardiac arrest | VENTRICULAR-FIBRILLATION | MILD HYPOTHERMIA | RENAL-FUNCTION | CARDIOPULMONARY BYPASS | CRITICALLY-ILL | MYOCARDIAL TEMPERATURE | OXYGEN-UPTAKE | BRETYLIUM TOSYLATE | PHARMACOLOGY & PHARMACY | HEMODYNAMIC-RESPONSES | INTENSIVE INSULIN THERAPY | Hypothermia, Induced - adverse effects | Risk Assessment | Drug Therapy - methods | Humans | Hypothermia, Induced - methods | Heart Arrest - physiopathology | Heart Arrest - therapy
Journal Article
Journal of Critical Care, ISSN 0883-9441, 2013, Volume 28, Issue 5, pp. 710 - 716
Abstract Purpose The purpose of the study is to evaluate the effectiveness of a vancomycin nomogram using actual body weight and the Modification of Diet in...
Critical Care | ICU | Vancomycin | Antibiotics | Dosing nomogram | VENTILATOR-ASSOCIATED PNEUMONIA | KIDNEY-FUNCTION | GUIDELINES | OUTCOMES | CRITICALLY-ILL PATIENTS | CRITICAL CARE MEDICINE | Intensive Care Units | Vancomycin - administration & dosage | Body Weight | Prospective Studies | Humans | Middle Aged | Critical Illness | Male | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Nomograms | Female | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Analysis | Kidney diseases | Index Medicus
Critical Care | ICU | Vancomycin | Antibiotics | Dosing nomogram | VENTILATOR-ASSOCIATED PNEUMONIA | KIDNEY-FUNCTION | GUIDELINES | OUTCOMES | CRITICALLY-ILL PATIENTS | CRITICAL CARE MEDICINE | Intensive Care Units | Vancomycin - administration & dosage | Body Weight | Prospective Studies | Humans | Middle Aged | Critical Illness | Male | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Nomograms | Female | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Analysis | Kidney diseases | Index Medicus
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 4/2015, Volume 21, Issue 3, pp. 260 - 265
No study has compared 2 different dosing strategies for argatroban titration nor has any published nomogram demonstrated improvement in outcomes. This study...
anticoagulants | nomogram | sliding scale | argatroban | direct thrombin inhibitors | THERAPY | THROMBOSIS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Pipecolic Acids - administration & dosage | Thrombocytopenia - drug therapy | Humans | Middle Aged | Nomograms | Heparin - administration & dosage | Female | Male | Aged | Antithrombins - administration & dosage | Thrombocytopenia - chemically induced | Heparin - adverse effects
anticoagulants | nomogram | sliding scale | argatroban | direct thrombin inhibitors | THERAPY | THROMBOSIS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Pipecolic Acids - administration & dosage | Thrombocytopenia - drug therapy | Humans | Middle Aged | Nomograms | Heparin - administration & dosage | Female | Male | Aged | Antithrombins - administration & dosage | Thrombocytopenia - chemically induced | Heparin - adverse effects
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 1/2004, Volume 38, Issue 1, pp. 25 - 29
BACKGROUND: Argatroban is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia (HIT). Argatroban is primarily cleared by hepatic...
Argatroban | Renal insufficiency | Heparin-induced thrombocytopenia | SERUM CREATININE | MANAGEMENT | VENOUS THROMBOEMBOLISM | FVIII-C | argatroban | renal insufficiency | heparin-induced thrombocytopenia | ELEVATION | PHARMACOLOGY & PHARMACY | PREDICTION | Kidney - physiology | Liver Function Tests | Injections, Intravenous | Kidney - drug effects | Prospective Studies | Drug Administration Schedule | Humans | Middle Aged | Pipecolic Acids - pharmacokinetics | Metabolic Clearance Rate | Treatment Outcome | Data Collection | Kidney Function Tests | Patient Selection | Pipecolic Acids - administration & dosage | Partial Thromboplastin Time | Pipecolic Acids - therapeutic use | Creatinine - blood | Aged
Argatroban | Renal insufficiency | Heparin-induced thrombocytopenia | SERUM CREATININE | MANAGEMENT | VENOUS THROMBOEMBOLISM | FVIII-C | argatroban | renal insufficiency | heparin-induced thrombocytopenia | ELEVATION | PHARMACOLOGY & PHARMACY | PREDICTION | Kidney - physiology | Liver Function Tests | Injections, Intravenous | Kidney - drug effects | Prospective Studies | Drug Administration Schedule | Humans | Middle Aged | Pipecolic Acids - pharmacokinetics | Metabolic Clearance Rate | Treatment Outcome | Data Collection | Kidney Function Tests | Patient Selection | Pipecolic Acids - administration & dosage | Partial Thromboplastin Time | Pipecolic Acids - therapeutic use | Creatinine - blood | Aged
Journal Article
Epilepsia, ISSN 0013-9580, 11/2000, Volume 41, Issue 11, pp. 1436 - 1443
Purpose: The study goal was to assess teratogenic effects of antiepileptic drugs (AEDs) through the use of a surveillance system (MADRE) of infants with...
antiepileptic drugs | INUTERO EXPOSURE | risk factors | MATERNAL EPILEPSY | NEURAL-TUBE DEFECTS | CARBAMAZEPINE | VALPROIC ACID | malformation registries | PREGNANCY | SPINA-BIFIDA | WOMEN | teratogenesis | COMMON ODDS RATIO | 2X2 CONTINGENCY-TABLES | Teratogenesis | Malformation registries | Antiepileptic drugs | Risk factors | CLINICAL NEUROLOGY | Product Surveillance, Postmarketing - statistics & numerical data | World Health Organization | Abnormalities, Drug-Induced - epidemiology | Global Health | Humans | Risk Factors | Databases, Factual - statistics & numerical data | Anticonvulsants - therapeutic use | Pregnancy | Anticonvulsants - adverse effects | Registries - statistics & numerical data | Abnormalities, Drug-Induced - etiology | Epilepsy - drug therapy | Female
antiepileptic drugs | INUTERO EXPOSURE | risk factors | MATERNAL EPILEPSY | NEURAL-TUBE DEFECTS | CARBAMAZEPINE | VALPROIC ACID | malformation registries | PREGNANCY | SPINA-BIFIDA | WOMEN | teratogenesis | COMMON ODDS RATIO | 2X2 CONTINGENCY-TABLES | Teratogenesis | Malformation registries | Antiepileptic drugs | Risk factors | CLINICAL NEUROLOGY | Product Surveillance, Postmarketing - statistics & numerical data | World Health Organization | Abnormalities, Drug-Induced - epidemiology | Global Health | Humans | Risk Factors | Databases, Factual - statistics & numerical data | Anticonvulsants - therapeutic use | Pregnancy | Anticonvulsants - adverse effects | Registries - statistics & numerical data | Abnormalities, Drug-Induced - etiology | Epilepsy - drug therapy | Female
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 7/2013, Volume 19, Issue 4, pp. 418 - 423
Desirudin, a subcutaneously (SC) administered direct thrombin inhibitor, is indicated for prevention of venous thromboembolic events (VTEs) after total joint...
anticoagulants | bleeding | deep venous thrombosis | thrombocytopenia | venous thromboembolism | RECOMBINANT HIRUDIN | FACTOR 4/HEPARIN ANTIBODIES | MANAGEMENT | EFFICACY | PREVENTION | PERIPHERAL VASCULAR DISEASE | COMPLICATIONS | THROMBOEMBOLISM | HEMATOLOGY | Recombinant Proteins - therapeutic use | Hirudins | Antithrombins - therapeutic use | Humans | Middle Aged | Anticoagulants - therapeutic use | Heparin - therapeutic use | Male | Young Adult | Aged, 80 and over | Adult | Female | Aged | Thrombosis - drug therapy | Thrombosis - prevention & control | Surgical Procedures, Operative - methods
anticoagulants | bleeding | deep venous thrombosis | thrombocytopenia | venous thromboembolism | RECOMBINANT HIRUDIN | FACTOR 4/HEPARIN ANTIBODIES | MANAGEMENT | EFFICACY | PREVENTION | PERIPHERAL VASCULAR DISEASE | COMPLICATIONS | THROMBOEMBOLISM | HEMATOLOGY | Recombinant Proteins - therapeutic use | Hirudins | Antithrombins - therapeutic use | Humans | Middle Aged | Anticoagulants - therapeutic use | Heparin - therapeutic use | Male | Young Adult | Aged, 80 and over | Adult | Female | Aged | Thrombosis - drug therapy | Thrombosis - prevention & control | Surgical Procedures, Operative - methods
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 02/2005, Volume 25, Issue 2, pp. 157 - 164
Study Objective. To determine the clinical utility of the chromogenic factor X level for conversion from argatroban to warfarin in hospitalized patients....
chromogenic factor X | INR | international normalized ratio | argatroban | warfarin | Argatroban | Warfarin | International normalized ratio | Chromogenic factor X | ANTICOAGULANTS | MANAGEMENT | LEPIRUDIN | PHARMACOLOGY & PHARMACY | HEPARIN-INDUCED THROMBOCYTOPENIA | VALUES | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Hospitals, University | Anticoagulants - therapeutic use | Male | Factor X - drug effects | Pipecolic Acids - pharmacology | Warfarin - pharmacology | Warfarin - therapeutic use | International Normalized Ratio | Blood Coagulation - drug effects | Anticoagulants - pharmacology | Pipecolic Acids - therapeutic use | Female | ROC Curve | Aged | Chromogenic Compounds
chromogenic factor X | INR | international normalized ratio | argatroban | warfarin | Argatroban | Warfarin | International normalized ratio | Chromogenic factor X | ANTICOAGULANTS | MANAGEMENT | LEPIRUDIN | PHARMACOLOGY & PHARMACY | HEPARIN-INDUCED THROMBOCYTOPENIA | VALUES | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Hospitals, University | Anticoagulants - therapeutic use | Male | Factor X - drug effects | Pipecolic Acids - pharmacology | Warfarin - pharmacology | Warfarin - therapeutic use | International Normalized Ratio | Blood Coagulation - drug effects | Anticoagulants - pharmacology | Pipecolic Acids - therapeutic use | Female | ROC Curve | Aged | Chromogenic Compounds
Journal Article
Critical Pathways in Cardiology, ISSN 1535-282X, 09/2011, Volume 10, Issue 3, pp. 117 - 127
Dabigatran etexilate is the first commercially available oral direct thrombin inhibitor. A single trial has studied patients at risk for stroke associated with...
dabigatran | atrial fibrillation | cost | venous thromboembolism | orthopedic surgery | Economics, Pharmaceutical | Venous Thromboembolism - prevention & control | Cost-Benefit Analysis | Humans | Pyridines - economics | Quality of Life | Antithrombin Proteins | Benzimidazoles - pharmacology | Pyridines - pharmacology | Benzimidazoles - economics | Dabigatran | Venous Thromboembolism - blood
dabigatran | atrial fibrillation | cost | venous thromboembolism | orthopedic surgery | Economics, Pharmaceutical | Venous Thromboembolism - prevention & control | Cost-Benefit Analysis | Humans | Pyridines - economics | Quality of Life | Antithrombin Proteins | Benzimidazoles - pharmacology | Pyridines - pharmacology | Benzimidazoles - economics | Dabigatran | Venous Thromboembolism - blood
Journal Article
Point of Care, ISSN 1533-029X, 03/2008, Volume 7, Issue 1, pp. 30 - 33
Journal Article
Epilepsia, ISSN 0013-9580, 01/2000, Volume 41, Issue 11, pp. 1436 - 1443
Purpose: The study goal was to assess teratogenic effects of antiepileptic drugs (AEDs) through the use of a surveillance system (MADRE) of infants with...
Teratogenesis | Neurology | Clinical Neurology | Malformation registries | Antiepileptic drugs | Risk factors
Teratogenesis | Neurology | Clinical Neurology | Malformation registries | Antiepileptic drugs | Risk factors
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 1981, Volume 203, Issue C, pp. 117 - 130
Direct liquid introduction interfaces for combined liquid chromatography-mass spectrometry (LC-MS) require a flow restriction to limit input liquid flow-rates...
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 1979, Volume 185, Issue C, pp. 529 - 547
The direct introduction of liquid solutions into the vacuum space of a mass spectrometer for liquid chromatography-mass spectrometry (LC-MS) purposes requires...
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9847, pp. 1059 - 1065
Summary Background Clinical outcomes after major surgery are poorly described at the national level. Evidence of heterogeneity between hospitals and...
Internal Medicine | POPULATION | MEDICINE, GENERAL & INTERNAL | NONCARDIAC SURGERY | POSTOPERATIVE COMPLICATIONS | CANCER-SURGERY | LONG-TERM SURVIVAL | SURGICAL QUALITY IMPROVEMENT | RISK | INPATIENT SURGERY | CRITICAL-CARE | MAJOR SURGERY | Critical Care - statistics & numerical data | Hospital Mortality | Surgical Procedures, Operative - mortality | Humans | Middle Aged | Europe - epidemiology | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Postoperative Care - methods | Adult | Female | Postoperative Care - statistics & numerical data | Aged | Length of Stay - statistics & numerical data | Cohort Studies | Austria | Demographic aspects | Mortality | United Kingdom | Portugal | Postoperative care | Health aspects | Risk factors | Anestesi och intensivvård | Anesthesiology and Intensive Care
Internal Medicine | POPULATION | MEDICINE, GENERAL & INTERNAL | NONCARDIAC SURGERY | POSTOPERATIVE COMPLICATIONS | CANCER-SURGERY | LONG-TERM SURVIVAL | SURGICAL QUALITY IMPROVEMENT | RISK | INPATIENT SURGERY | CRITICAL-CARE | MAJOR SURGERY | Critical Care - statistics & numerical data | Hospital Mortality | Surgical Procedures, Operative - mortality | Humans | Middle Aged | Europe - epidemiology | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Postoperative Care - methods | Adult | Female | Postoperative Care - statistics & numerical data | Aged | Length of Stay - statistics & numerical data | Cohort Studies | Austria | Demographic aspects | Mortality | United Kingdom | Portugal | Postoperative care | Health aspects | Risk factors | Anestesi och intensivvård | Anesthesiology and Intensive Care
Journal Article